Record updated: Nov. 21, 2018, 7:13 p.m. by awhite.

Edits to 'https://fairsharing.org/FAIRsharing.dvxkzb' by 'awhite' at 19:13, 21 Nov 2018 (not approved):

	'organizations' has been modified:
		Before:
			U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA|http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/|Funds
			Pharmaceutical and Medical Device Regulatory Science Society of Japan Tokyo|https://www.pmda.go.jp/english/|Undefined
		After:
			US Food and Drug Administration|http://www.fda.gov|Undefined
			Pharmaceuticals and Medical Device Agency (Japan)|https://www.pmda.go.jp/english/|Undefined
			CDISC|https://www.cdisc.org/|Maintains
			Innovative Medicines Initiative (IMI), Europe|http://www.imi.europa.eu|Undefined
		Added:
			US Food and Drug Administration|http://www.fda.gov|Undefined
			Pharmaceuticals and Medical Device Agency (Japan)|https://www.pmda.go.jp/english/|Undefined
			CDISC|https://www.cdisc.org/|Maintains
			Innovative Medicines Initiative (IMI), Europe|http://www.imi.europa.eu|Undefined
		Removed:
			U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA|http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/|Funds
			Pharmaceutical and Medical Device Regulatory Science Society of Japan Tokyo|https://www.pmda.go.jp/english/|Undefined

	'supportLinks' has been modified:
		Before:
			forum|http://www.cdisc.org/forums/analysis-data-model-adam
			online documentation|http://www.cdisc.org/adam-v2.1-%26-adamig-v1.0
			training|http://www.cdisc.org/adam-course
			training|https://www.cdisc.org/education/course/introduction-adam
		After:
			training|https://www.cdisc.org/education/course/adam-primer
			training|https://www.cdisc.org/education/course/adam-theory-and-application
		Added:
			training|https://www.cdisc.org/education/course/adam-primer
			training|https://www.cdisc.org/education/course/adam-theory-and-application
		Removed:
			forum|http://www.cdisc.org/forums/analysis-data-model-adam
			online documentation|http://www.cdisc.org/adam-v2.1-%26-adamig-v1.0
			training|http://www.cdisc.org/adam-course
			training|https://www.cdisc.org/education/course/introduction-adam

	'publications' has been modified:
		Before:
			A Cytel Case Study: The Use of CDISC Standards in Unilevers Cosmetics and Food Products Trials|Meghana Bhagwat|https://www.cdisc.org/system/files/all/article/application/pdf/cytel_unilever_cdisc_av_4final.pdf|
		After:
		Added:
		Removed:
			A Cytel Case Study: The Use of CDISC Standards in Unilevers Cosmetics and Food Products Trials|Meghana Bhagwat|https://www.cdisc.org/system/files/all/article/application/pdf/cytel_unilever_cdisc_av_4final.pdf|

            

Edits to 'https://fairsharing.org/FAIRsharing.dvxkzb' by 'awhite' at 16:18, 07 Nov 2018 (approved):

	'organizations' has been modified:
		Before:
			U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA|http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/|Funds
			CDISC, Austin, TX, USA|http://www.cdisc.org/|Maintains
			Pharmaceutical and Medical Device Regulatory Science Society of Japan Tokyo|https://www.pmrj.jp/eng/index_e.html|Undefined
		After:
			U.S. Food and Drug Administration (FDA), Silver Spring, MD, USA|http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/|Funds
			Pharmaceuticals and Medical Device Agency, Japn|https://www.pmda.go.jp/english/|Undefined
		Added:
			Pharmaceuticals and Medical Device Agency, Japn|https://www.pmda.go.jp/english/|Undefined
		Removed:
			CDISC, Austin, TX, USA|http://www.cdisc.org/|Maintains
			Pharmaceutical and Medical Device Regulatory Science Society of Japan Tokyo|https://www.pmrj.jp/eng/index_e.html|Undefined

	'contact' has been modified:
		Before: john smith
		After: Ann White

	'homepage' has been modified:
		Before: http://www.cdisc.org/adam
		After: https://www.cdisc.org/standards/foundational/adam

	'description' has been modified:
		Before: The CDISC Analysis Data Model (ADaM) document specifies the fundamental principles and standards to follow in the creation of analysis datasets and associated metadata. ADaM supports efficient generation, replication, and review of analysis results.  ADaM provides a framework that enables analysis of the data, while at the same time allowing reviewers and other recipients of the data to have a clear understanding of the data's lineage from collection to analysis to results. Whereas ADaM is optimized to support data derivation and analysis, CDISC's Study Data Tabulation Model (SDTM) is optimized to support data tabulation.
		After: ADaM defines dataset and metadata standards that support the efficient generation, replication, and review of clinical trial statistical analyses, and traceability among analysis results, analysis data, and data represented in the Study Data Tabulation Model (SDTM).?



	'publications' has been modified:
		Before:
			A Cytel Case Study: The Use of CDISC Standards in Unilevers Cosmetics and Food Products Trials|Meghana Bhagwat,  Ed by Andrea Vadakin|https://www.cdisc.org/system/files/all/article/application/pdf/cytel_unilever_cdisc_av_4final.pdf|
		After:
			A Cytel Case Study: The Use of CDISC Standards in Unilevers Cosmetics and Food Products Trials|Meghana Bhagwat|https://www.cdisc.org/system/files/all/article/application/pdf/cytel_unilever_cdisc_av_4final.pdf|
		Added:
			A Cytel Case Study: The Use of CDISC Standards in Unilevers Cosmetics and Food Products Trials|Meghana Bhagwat|https://www.cdisc.org/system/files/all/article/application/pdf/cytel_unilever_cdisc_av_4final.pdf|
		Removed:
			A Cytel Case Study: The Use of CDISC Standards in Unilevers Cosmetics and Food Products Trials|Meghana Bhagwat,  Ed by Andrea Vadakin|https://www.cdisc.org/system/files/all/article/application/pdf/cytel_unilever_cdisc_av_4final.pdf|

            

Edits to 'https://fairsharing.org/FAIRsharing.dvxkzb' by 'The FAIRsharing Team' at 09:42, 12 Jul 2018 (approved):

	'miriam_url' has been modified:
		Before: None
		After: